Drug combination containing astragalus and use thereof

A composition and technology of astragalus extract, applied in the field of pharmaceutical composition containing astragalus and its application, can solve problems such as rough production process, unguaranteed curative effect, and lax quality control

Inactive Publication Date: 2012-01-25
GUANGDONG ZIJIN ZHENGTIAN PHARMA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many similar products on the market, but most of them have rough production process, lax quality control, shoddy goods and false ones, and the curative effect cannot be guaranteed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug combination containing astragalus and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment 1: 45 parts of Radix Astragali. The composition is superfinely pulverized and mixed with 15 parts of levamisole hydrochloride and 10 parts of vitamin C for use.

Embodiment 2

[0012] Example 2: 45 parts of Radix Astragali were extracted efficiently, mixed with 15 parts of levamisole hydrochloride and 10 parts of vitamin C, and an appropriate amount of excipients and binders were added to make granules.

Embodiment 3

[0013] Example 3: 40 parts of Astragalus membranaceus were extracted efficiently, and 15 parts of levamisole hydrochloride and 15 parts of vitamin C were added to prepare a solution. 1 ml of the medicinal solution was equivalent to 1 g of raw medicinal materials.

[0014] The above examples are only for further description of the present invention, and the scope of the present invention is not limited by the examples given.

[0015] Some experimental results report:

[0016] A test report on a medicinal composition containing Radix Astragali and its application

[0017] A total of 103 piglets from a pig farm that had been diagnosed with classical swine fever were selected and randomly divided into two groups, A and B. Keep them in captivity, keep them clean, ventilate in time, and keep records. Full-price feed, regular feeding, free drinking water, unified management. Group A added this extract (co-produced by Guangdong Zijinzhengtian Pharmaceutical Co., Ltd. and Guangdong...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a drug combination containing astragalus and a use thereof. The drug combination contains astragalus or an astragalus extractive or a derivative thereof capable of being received chemically. The drug combination comprises the following components: 100 parts of astragalus and 1-50 of levamisole hydrochloride. On the basis, the following one or more components can be increased, but not limited: 20-150 parts of vitamin C. The use method and the dosage of the combination are shown as follows: a solid preparation is used after being mixed by 0.1-10.0 percent of complete feeds; and a liquid preparation is drunk after the water of 250-500 kg is added in the liquid preparation of 100 ml. The combination has the main function of inducing a human body to generate the interferon, promoting the antibody formation and adjusting the immunologic function of the human body. The drug combination is used for simulating an immune system of an animal body, adjusting the immunity, enhancing the disease resistance, reducing the disease incidence and assisting to treat the virus infection.

Description

technical field [0001] The invention relates to a pharmaceutical composition containing Astragalus membranaceus and its use, which belongs to the field of traditional Chinese medicine health products for animals in the animal husbandry industry. The pharmaceutical composition is mainly used to stimulate the immune system of animals, regulate immunity, enhance disease resistance, and reduce morbidity. rate, and adjuvant therapy for viral infections. Background technique [0002] With the development of the economy and the improvement of living standards, people's demand for animal food is increasing, and the requirements for food safety and quality are also getting higher and higher. This provides more markets for animal husbandry, but also puts forward higher requirements. At present, the scale of animal husbandry in my country is expanding, the breeding density is increasing, and the incidence of animal diseases is also increasing accordingly. Moreover, there are more and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/481A61P37/04A61P31/14A23K1/14A61K31/429A61K31/375
Inventor 王庆福刘易通李振天
Owner GUANGDONG ZIJIN ZHENGTIAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap